@article {Yu2021.10.15.21265069, author = {Jing Yu and Anita Szabo and Alistair T Pagnamenta and Ahmed Shalaby and Edoardo Giacopuzzi and Jenny Taylor and Deborah Shears and Nikolas Pontikos and Genevieve Wright and Michel Michaelides and Stephanie Halford and Susan Downes and Genomics England Research Consortium}, title = {SVRare: discovering disease-causing structural variants in the 100K Genomes Project}, elocation-id = {2021.10.15.21265069}, year = {2022}, doi = {10.1101/2021.10.15.21265069}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Discovery of disease-causing structural variants (dcSV) from whole genome sequencing data is difficult due to high number of false positives and a lack of efficient way to estimate allele frequency. Here we introduce SVRare, an application that aggregates structural variants (SV) called by other tools, and efficiently annotates rare SVs to aid dcSVs discovery.Applied in the Genomics England (GEL) research environment to data from the 100K Genomes Project, SVRare aggregated 554,060,126 SVs called by Manta and Canvas in all the 71,408 participants in the rare-disease arm. From a pilot study of 4313 families, SVRare identified 36 novel protein-coding disrupting SVs on diagnostic grade genes that may explain proband{\textquoteright}s phenotype. It is estimated that SVRare can increase SV-based diagnosis yield by at least 4-fold. We also performed a genome-wide association study, and uncovered clusters of dcSVs in genes with known pathogenicity, such as PKD1/2 - cystic kidney diseases and LDLR - familial hypercholesterolaemia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJing Yu{\textquoteright}s salary was supported by UKIRDC (RetinaUK)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:United Kingdom National Research Ethics Service Research Ethics Committee for East of England - Cambridge South Research Ethics Committee gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available in the manuscript and online at https://github.com/Oxford-Eye/SVRare https://github.com/Oxford-Eye/SVRare}, URL = {https://www.medrxiv.org/content/early/2022/02/15/2021.10.15.21265069}, eprint = {https://www.medrxiv.org/content/early/2022/02/15/2021.10.15.21265069.full.pdf}, journal = {medRxiv} }